◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
南京医药 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 53.7B 53.6B 50.2B 45.1B 39.8B
Revenue Growth % 0.2% 6.7% 11.3% 13.3% --
Total Revenue 53.7B 53.6B 50.2B 45.1B 39.8B
Cost Of Revenue 50.3B 50.3B 47.0B 42.2B 37.3B
+Gross Profit 3.4B 3.3B 3.3B 2.9B 2.5B
Gross Margin % 6.3% 6.2% 6.5% 6.5% 6.4%
Total Operating Cost 52.7B 52.6B 49.3B 44.3B 39.1B
Selling Expenses 1.1B 1.2B 1.2B 1.1B 953.0M
Admin Expenses 518.0M 517.0M 487.0M 433.0M 405.0M
Rd Expenses 30.6M 36.2M 27.4M 21.0M 16.0M
Finance Expenses 516.0M 535.0M 435.0M 442.0M 360.0M
+Operating Income 1.0B 1.0B 934.0M 846.0M 676.0M
Operating Margin % 1.9% 1.9% 1.9% 1.9% 1.7%
Non Operating Income 12.4M 2.6M 8.1M 17.0M 32.5M
Non Operating Expenses 32.4M 31.9M 36.4M 23.8M 31.0M
Investment Income 4.0M 8.6M -48.6M -87.7M -92.9M
Fair Value Change Income -- -- -- -- --
Asset Disposal Income 4.1M 2.2M 24.0M 60.5M 66.1M
Asset Impairment Loss 18.3M 6.2M 6.8M 8.6M 15.0M
Other Income 30.6M 39.4M 28.8M 15.5M 35.1M
Income Before Tax 1.0B 978.0M 906.0M 839.0M 678.0M
Income Tax 260.0M 265.0M 190.0M 228.0M 208.0M
+Net Income 743.0M 713.0M 716.0M 611.0M 470.0M
Net Margin % 1.4% 1.3% 1.4% 1.4% 1.2%
Net Income Attributable 571.0M 578.0M 596.0M 505.0M 376.0M
Minority Interest 172.0M 135.0M 120.0M 105.0M 93.6M
Eps Basic 0.44 0.45 0.48 0.49 0.36
Eps Diluted 0.44 0.45 0.48 0.49 0.36
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 4.6B 2.4B 2.3B 2.1B 1.5B
Trading Financial Assets -- -- -- -- --
Accounts Receivable 12.0B 11.7B 14.3B 10.8B 9.1B
Notes Receivable 572.0M 2.4B 2.4B 2.5B 3.0B
Notes And Accounts Receivable 12.6B 14.1B 16.7B 13.3B 12.1B
Prepayments 890.0M 894.0M 1.2B 1.1B 923.0M
Inventory 6.3B 5.8B 5.8B 4.5B 4.1B
Total Current Assets 27.8B 26.0B 29.3B 23.5B 21.2B
Long Term Equity Investment 70.6M 42.4M 12.4M 12.9M 13.8M
Fixed Assets -- 1.1B 1.2B 1.1B --
Fixed Assets Total 1.4B 1.1B 1.2B 1.1B 1.1B
Construction In Progress -- 130.0M 80.2M 153.0M 87.8M
Construction In Progress Total 237.0M 130.0M 80.2M 153.0M 87.8M
Intangible Assets 216.0M 219.0M 245.0M 268.0M 282.0M
Long Term Deferred Expenses 44.6M 43.3M 36.9M 34.2M 52.8M
Total Non Current Assets 2.9B 2.4B 2.4B 2.4B 2.2B
Total Assets 30.7B 28.4B 31.7B 25.9B 23.4B
Short Term Borrowings 2.0B 1.8B 1.8B 3.7B 5.1B
Accounts Payable 7.4B 6.9B 7.2B 5.5B 4.9B
Advance Receipts -- -- -- -- --
Contract Liabilities 279.0M 104.0M 219.0M 74.8M 75.2M
Total Current Liabilities 17.1B 18.6B 22.3B 17.5B 17.2B
Long Term Borrowings 200.0M 1.1B 1.6B 981.0M --
Total Non Current Liabilities 5.8B 2.6B 2.7B 3.1B 1.4B
Total Liabilities 22.9B 21.2B 25.0B 20.7B 18.6B
Paid In Capital 1.3B 1.3B 1.3B 1.0B 1.0B
Capital Reserve 2.5B 2.5B 2.4B 1.7B 1.7B
Surplus Reserve 322.0M 278.0M 237.0M 197.0M 168.0M
Retained Earnings 2.6B 2.3B 2.0B 1.6B 1.2B
Minority Equity 950.0M 820.0M 695.0M 627.0M 563.0M
Equity Attributable 6.8B 6.4B 6.0B 4.6B 4.3B
Total Equity 7.8B 7.3B 6.7B 5.2B 4.8B
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 56.2B 59.8B 49.2B 46.8B 39.3B
Tax Refunds Received 11.1M 19.3M -- -- --
Total Operating Cash Inflow 56.6B 60.6B 51.9B 47.8B 39.6B
Cash Paid For Goods 51.3B 53.2B 48.9B 44.8B 38.3B
Cash Paid To Employees 979.0M 979.0M 900.0M 838.0M 714.0M
Taxes Paid 1.0B 981.0M 1.0B 742.0M 555.0M
Total Operating Cash Outflow 54.5B 58.7B 52.5B 47.1B 40.8B
Operating Cash Flow 2.1B 1.9B -682.0M 695.0M -1.2B
Total Investing Cash Inflow 10.4M 9.0M 96.0M 84.0M 59.5M
Total Investing Cash Outflow 572.0M 182.0M 155.0M 309.0M 276.0M
Investing Cash Flow -562.0M -173.0M -59.3M -225.0M -216.0M
Cash From Borrowings 16.6B 20.5B 18.8B 25.0B 21.1B
Dividends And Interest Paid 618.0M 681.0M 553.0M 991.0M 420.0M
Debt Repayments 21.3B 28.4B 22.8B 28.0B 22.5B
Total Financing Cash Inflow 21.2B 28.1B 23.9B 29.1B 23.7B
Total Financing Cash Outflow 22.0B 29.2B 23.4B 29.1B 22.9B
Financing Cash Flow -840.0M -1.2B 467.0M 30.8M 749.0M
Net Change In Cash 734.0M 576.0M -275.0M 502.0M -619.0M
Ending Cash Balance 2.9B 2.2B 1.6B 1.9B 1.4B
Capex 545.0M 158.0M 155.0M 307.0M 247.0M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...